Sub Banner Image

Axsome Therapeutics Stock Tumbles As Alzheimer's Studies Reveal Mixed Results: Retail Sentiment Remains Bullish

Equities

Stocktwits

·

·

Barchart

Axsome still plans to submit its AXS-05 drug to the U.S. FDA for approval.

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.